|
Written Best Practices
These are qualitative findings from large, interview-based Research and Consulting projects with company leaders that explain how and why they have found the practice to work for them. Best practices are often in the format "do this to achieve that."
 | Brand Management and Product Leadership |
| |
| Business Operations |
| |
| Clinical Operations |
| |
| Customer Service |
| |
| Human Resources |
| |
| Knowledge Management |
| |
| Market Research, Analytics and Forecasting |
| |
| Marketing Management |
| |
 | Medical Affairs |
| |
| Professional and Advocacy Relations: Launching International Efforts 
|
Globalization has made access to new markets fundamental for creating new opportunities for market leadership and for partnerships with other companies seeking organizations with a solid global presence... (ID 4264)
Companies Profiled: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, more ...
Price: $516.95
| |
|  |
| | |
| | |
| Building Effective Structures for Patient Advocacy Relations 
|
As patient advocacy groups become more sophisticated, successful companies are developing formalized structures designed to meet the needs of these key stakeholders... (ID 4261)
Companies Profiled: Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, more ...
Price: $769.95
| |
| |
| | |
| | |
| Measuring Medical Affairs Performance 
|
Study Overview
While the medical affairs function arguably plays the most crucial role in the success or failure of a pharmaceutical company, investments made to this function are hard to measure in terms of return on investment... (ID 4632)
Companies Profiled: Abbott, Sanofi-aventis, Amgen, AstraZeneca, more ...
Price: $458.95
| |
| |
| Medical Affairs Staffing & Spend: Maximizing Value, Decreasing Cost
|
Study Overview
With new pressures and regulations, pharmaceutical companies are looking for more ways then ever to decrease the cost of maintaining their medical affairs department, mostly through staffing and expenditure... (ID 4631)
Companies Profiled: Abbott, Sanofi-aventis, Amgen, AstraZeneca, more ...
Price: $1584.95
| |
| |
| | |
| | |
| | |
| | |
| New Product Development |
| |
| Patient Focused Services |
| |
| Product Launch |
| |
| Quality, Compliance and Regulatory |
| |
| Sales and Marketing |
| |
| Sales Leadership |
| |
|